LIfT BioSciences
Developer of a biotech platform designed for CAR neutrophil cell therapy that helps overcome the limitations of current therapies in solid tumors. The company's platform offers immunomodulatory alpha ...
Valuation
$0
Share Price
N/A
Total Raised
$21.8M
Last Round
N/A